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Abstract: Despite numerous studies on women’s cardiac health throughout the past decade, the
number of female deaths caused by cardiovascular disease still rises and remains the leading cause
of death in women in most areas of the world. Novel studies have demonstrated that cardiovascular
disease, and more specifically coronary artery disease presentations in women, are different than
those in men. In addition, pathology and pathophysiology of the disease present significant
gender differences, which leads to difficulties concerning diagnosis, treatment and outcome of the
female population. The reason for this disparity is all steps for female cardiovascular disease
evaluation, treatment and prevention are not well elucidated; and an area for future research. This
review brings together the most recent studies published in the field of coronary artery disease
in women and points out new directions for future investigation on some of the important issues.
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Introduction
The first female-specific recommendations for preventive cardiology were published in
1999 (Mosca et al 1999). Even though research in the treatment of cardiovascular disease
(CVD) had advanced in many areas, it remains the leading cause of death in women in
most parts of the world. Studies have shown that 500 thousand women die of CVD every
year in the United States, somewhat near one death every minute (American Heart
Association 2003). Such index exceeds not only the number of deaths in men, but also the
next seven causes of death in women combined, and more importantly, coronary artery
disease (CAD) is believed to be the major cause responsible for these deaths (American
Heart Association 2003). Over a quarter of a million deaths per year are attributed to CAD
alone in the United States (Merz et al 2004). Although already high, these figures are
expected to rise even more during the next decades, due to an increase of diabetes and
obesity, as well as the aging of the world population (Merz et al 2004).
Even though women have a higher frequency of chest pain/angina than men, the
incidence of obstructive CAD in the female population is lower when compared with
men with similar symptoms (Kenedy et al 1982; Diamond et al 1983; Merz et al 1999). In
addition, it would appear that young women with obstructive CAD have a worse
prognosis after acute myocardial infarction (AMI), whereas older women in similar
circumstances often present with larger number of comorbidities that adversely influence
the outcome, when compared to men (Coronado et al 1997). Women with acute coronary
syndromes (ACS) are also less likely to receive rapid effective diagnosis and treatment
than are men (Ayanian and Epstein 1991; Maynard et al 1996; Pope
et al 2000).
Regarding the North American population, the Women’s Ischemic Syndrome
Evaluation (WISE) study workshop (Hayes et al 2004; Maseri 2004; Nabel et al 2004;
Pepine et al 2004; Shaw et al 2004; Waters et al 2004) from the National Heart, Lung and
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Abstract: A 41-year old female patient was admitted with acute onset of dyspnea and chest pain. 
Previous history revealed asthma, chronic sinusitis and eosinophilic proctitis. Electrocardiogram 
showed anterior ST-segment elevations and inferior ST-segment depression. Immediate heart 
catheterization revealed a distally occluded left anterior descending coronary artery, the occlu-
sion being reversible after nitroglycerine. Cardiac magnetic resonance imaging was consistent 
with perimyocarditis. Hypereosinophilia and IgE elevation were present and Churg-strauss 
syndrome was diagnosed.
Keywords: Churg-Strauss syndrome (CSS), carditis, cardiac MRI
Introduction
Churg and Strauss initially described the syndrome as a necrotising vasculitis of 
medium-to-small sized veins and arteries, associated with eosinophilic inﬁ  ltration 
around the vessels and adjacent tissues (Churg and Strauss 1951). Cardiac involve-
ment is a leading cause of mortality and a common clinical manifestation (Conron 
and Beynon 2000). About 40% of patients face cardiac problems including symptoms 
of congestive heart failure, pericardial effusions, or arterial hypertension (Solans et al 
2001; McGavin et al 2002; Lau et al 2004). Other consequences include myocarditis 
and intracardiac thrombosis (Ommen et al 2000). Although vasospastic angina and 
myocardial infarction are unusual clinical manifestations of Churg-Strauss syndrome 
(CSS), the case we report suggests that it should be suspected in CSS cases.
Case report
A 41-year old female was admitted to our emergency department with acute respira-
tory distress and severe chest pain. Her symptoms had developed progressively over 
the last two weeks along with difﬁ  culties in activities that required fast walking or 
climbing stairs. She also experienced general weakness and systemic symptoms such 
as malaise the weeks before.
Her past medical history revealed no previous hospitalizations and no cardiovas-
cular risk factors. In 2001, asthma was diagnosed. Since 2003, the patient suffered 
from chronic sinusitis and otitis media. Due to diarrhea in 2003, a colonoscopy was 
performed and proctitis was diagnosed. The histological results of the colon biopsy 
revealed extravascular eosinophilic inﬁ  ltrates. The diagnosis of CSS was not considered 
at that time since no differential white blood count (WBC) has been done.
Initial laboratory ﬁ  ndings revealed Troponin T elevation (0.40 µg/l, reference 
value 0.01 µg/l) as well as increased white blood cells (19,100/µl) and platelets 
(399,000/µl). In the course of diagnostic investigation differential WBC was per-
formed and revealed eosinophilia of 68.2%, corresponding with an absolute value of 
9,600/µl. C-reactive protein (CRP) and serum-creatinine as well as the glomerular Vascular Health and Risk Management 2006:2(4) 465–475
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ﬁ  ltration rate were in the normal range, however IgE was 
elevated (367 IE/ml; reference value 1–100 IE/ml). ANA, 
anti-ds-DNA, ENA and ANCA were negative. Baseline 
electrocardiogram (ECG) showed ST-segment elevations in 
leads II, III and aVF and pronounced T inversions in leads 
V5 and V6.
Coronary angiography revealed a distally occluded left 
anterior descending coronary artery (Figure 1A), the occlu-
sion being reversible after nitroglycerine (Figure 1B). The 
maximum CK-level was 350 U/l (reference value 145 U/l) 
and CK-MB 44 U/l (reference value 24 U/l), respectively. 
A contrast-enhanced magnetic resonance imaging (MRI) of 
the heart was performed to evaluate the extent of myocardial 
necrosis and the presence/absence of myocarditis.
A contrast-enhanced phase sensitive inversion recovery 
sequence (PSIR) was used for the detection of late enhance-
ment which is known to indicate scar formation/ﬁ  brosis or 
can be associated with acute myocarditis. A bandlike suben-
docardial hyperintensity was detected in the interventricular 
septum (Figure 2A). The distal occlusion of the LAD might 
have caused the subendocardial late enhancement ﬁ  nding in 
the apical septum. However, the late enhancement ﬁ  nding in 
the basal and medial part of the septum extended the territory 
that was supplied by the distal LAD and were most likely due 
to myocarditis. In addition, a small pericardial effusion was 
present. Follow up MRI demonstrated only mild regional wall 
hypokinesia of the apical septum, anterior and inferior wall.
The presence of asthma, hypereosinophilia >10%, chronic 
sinusitis, and eosinophilic proctitis represent 4 of the 6 ACR 
criteria required for the classiﬁ  cation of CSS. In addition, 
cardiac involvement was present due to coronary vasculitis 
and perimyocarditis which lead us to initiate the combina-
tion therapy of glucocorticoids and cyclophosphamide. Oral 
corticosteroids were applied with an initial dosage of 50 mg 
prednisolone per day (1 mg/kg/d). In addition, monthly intra-
venous cyclophosphamide with 500 mg/m2 BSA increased 
to 750 mg/m2 BSA was initiated and continued over three 
months. Symptoms, eosinophilia, IgE count, Troponin 
T- and CK levels decreased to normal ranges (Figure 3). 
Azathioprine with 2 × 50 mg per day was initiated to maintain 
B A
Figure 1 Angiogram of the left coronary artery. The left anterior descending coronary artery (LAD) is distally occluded (arrow in A); after intracoronary application of 
nitroglycerine the LAD is open (arrows in B), but demonstrating a long, severely diseased coronary segment that is signiﬁ  cantly stenosed. Because of the long coronary 
segment involved, the small diameter and the suspicion of inﬂ  ammatory origin of the stenosis, percutaneous coronary intervention was not attempted.Vascular Health and Risk Management 2006:2(4) 465–475
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circumstances often present with larger number of comorbidities that adversely influence
the outcome, when compared to men (Coronado et al 1997). Women with acute coronary
syndromes (ACS) are also less likely to receive rapid effective diagnosis and treatment
than are men (Ayanian and Epstein 1991; Maynard et al 1996; Pope
et al 2000).
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remission. Oral corticosteroids were continuously tapered 
over a period of 20-weeks to a dosage of 5 mg per day 
and after additional 4-months, the patient had reached a 
stable remission. After 4 and 12-months, small areas of late 
enhancement persisted in the apical septum on MRI with 
regional hypokinesia in this region (Figure 2B, 2C).
Discussion
We describe a patient who presented with an acute coronary 
syndrome, eosinophilia, and elevated IgE-levels. The diagno-
sis of CSS was made. CSS is a rare diffuse vasculitis that is 
almost invariably accompanied by severe asthma. Although 
overall prognosis is good, diffuse organ involvement, in 
Figure 2A Magnetic resonance imaging of the left ventricle. Phase sensitive T1-weighted contrast based late enhancement sequence (PSIR). A subendocardial bandlinke 
hyperintensity in the interventricular septum was found in the four chamber view and short axis orientation (arrow). A small pericardial effusion was present.
Figure 2B Follow-up after four months. Subendocardial late enhancement persisted, though smaller in extension as seen in this PSIR late enhancement image of the four 
chamber view and short axis orientation. No pericardial effusion.Vascular Health and Risk Management 2006:2(4) 465–475
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Figure 2C After 12 months, further reduction of the basal septal late enhancement area was present, however there is persisting late enhancement in the apical septum 
with wall thinning.
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Figure 3 Eosinophils and creatine kinase (CK) levels during three months follow-up. In August 2004 prednisolone 50 mg daily was administered. The eosinophils and CK 
levels decreased continuously under prednisolone treatment.Vascular Health and Risk Management 2006:2(4) 465–475
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particular cardiovascular and rare involvement of the central 
nervous system or renal system, suggests a poorer prognosis 
and can be fatal (Noth et al 2003). The American College 
of Rheumatology (ACR) 1990 criteria for the classiﬁ  cation 
of CSS do not emphasize the cardiac symptoms (Masi et al 
1990). However, a review of the literature indicates that 
cardiac involvement is a poor prognostic factor, known 
to be a leading cause of mortality and a common clinical 
manifestation in CSS. Of note, patients with heart involve-
ment are mainly ANCA-negative which is in agreement of 
this case (Sable-Fourtassou et al 2005; Sinico et al 2006). 
Cardiac inﬂ  ammation may include eosinophilic endomyo-
carditis, coronary vasculitis, valvular heart disease, conges-
tive heart failure, hypertension, and pericarditis (Morgan 
et al 1989; Ramakrishna and Midthun 2001; Petrakopoulou 
et al 2005).
Fixed lesions, slowly regressing under therapy, have 
been more conﬁ  dently related to CSS. However, coronary 
spasms have been seen in CSS patients, and this is fre-
quently not clinically symptomatic, which might also be 
responsible for underdiagnosing CSS. Since the patients 
with cardiac involvement are at high risk, intravenous or 
oral cyclophosphamide in association with glucocorticoids 
are required (Noth et al 2003). The switch to another less 
toxic immunosuppressant after remission is currently not 
evidence-based medicine.
Conclusion
Because of its multiorgan involvement, clinical diagnosis 
of CSS may be difﬁ  cult to obtain. As reported here, the 
disease may present with clinical ﬁ  ndings of an acute 
coronary syndrome. The association of perimyocarditis, 
hypereosinophilia, and elevated IgE-levels with a history 
of asthma were the key data to establish the diagnosis of 
CSS. Biopsy conﬁ  rmation of vasculitis is complicated by 
the unpredictable and often sequential onset of disease 
manifestations of the various organs involved and by its 
incomplete evolution even in the affected organs. Mere MRI 
ﬁ  ndings in patients free of cardiac symptoms should not 
be considered as basis for treatment decisions. However, 
MRI might be a helpful tool in the initial evaluation of 
CSS patients showing clinical or laboratory evidence of 
heart involvement. Consequently, this condition requires 
early and aggressive treatment with glucocorticoids in 
combination with cyclophosphamide.
However, onset of asthma associated with pulmonary 
inﬁ  ltrates, renal disease, mononeuritis multiplex or, as pre-
sented by our patient, a combination of cardiac manifestation 
and proctitis should alert physicans to consider CSS as a 
potential differentential diagnosis in patients with these con-
ditions and in particular with an acute coronary syndrome.
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Abstract: Despite numerous studies on women’s cardiac health throughout the past decade, the
number of female deaths caused by cardiovascular disease still rises and remains the leading cause
of death in women in most areas of the world. Novel studies have demonstrated that cardiovascular
disease, and more specifically coronary artery disease presentations in women, are different than
those in men. In addition, pathology and pathophysiology of the disease present significant
gender differences, which leads to difficulties concerning diagnosis, treatment and outcome of the
female population. The reason for this disparity is all steps for female cardiovascular disease
evaluation, treatment and prevention are not well elucidated; and an area for future research. This
review brings together the most recent studies published in the field of coronary artery disease
in women and points out new directions for future investigation on some of the important issues.
Keywords: coronary artery disease, women, risk factors, prevention, diagnosis, treatment.
Introduction
The first female-specific recommendations for preventive cardiology were published in
1999 (Mosca et al 1999). Even though research in the treatment of cardiovascular disease
(CVD) had advanced in many areas, it remains the leading cause of death in women in
most parts of the world. Studies have shown that 500 thousand women die of CVD every
year in the United States, somewhat near one death every minute (American Heart
Association 2003). Such index exceeds not only the number of deaths in men, but also the
next seven causes of death in women combined, and more importantly, coronary artery
disease (CAD) is believed to be the major cause responsible for these deaths (American
Heart Association 2003). Over a quarter of a million deaths per year are attributed to CAD
alone in the United States (Merz et al 2004). Although already high, these figures are
expected to rise even more during the next decades, due to an increase of diabetes and
obesity, as well as the aging of the world population (Merz et al 2004).
Even though women have a higher frequency of chest pain/angina than men, the
incidence of obstructive CAD in the female population is lower when compared with
men with similar symptoms (Kenedy et al 1982; Diamond et al 1983; Merz et al 1999). In
addition, it would appear that young women with obstructive CAD have a worse
prognosis after acute myocardial infarction (AMI), whereas older women in similar
circumstances often present with larger number of comorbidities that adversely influence
the outcome, when compared to men (Coronado et al 1997). Women with acute coronary
syndromes (ACS) are also less likely to receive rapid effective diagnosis and treatment
than are men (Ayanian and Epstein 1991; Maynard et al 1996; Pope
et al 2000).
Regarding the North American population, the Women’s Ischemic Syndrome
Evaluation (WISE) study workshop (Hayes et al 2004; Maseri 2004; Nabel et al 2004;
Pepine et al 2004; Shaw et al 2004; Waters et al 2004) from the National Heart, Lung and
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